Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
fda
life sciences
national
national blog main
3
×
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drug prices
indiana blog main
indiana top stories
loxo oncology
new york blog main
novartis
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acquisition
adaptimmune
allergan
allogeneic
alnylam
american society of clinical oncology (asco)
anti-inflammatory drugs
What
home
3
×
annual
days
drug
ahead
airport
ambien
american
apocalypse
approved
asco
atrophy
attendees
attention
beds
biotech
camp’s
cancer
cash
celgene
chicago
city
clinical
combinations
community’s
daily
evrysdi
expanding
fallout
fda
focus
friday
gone
green
intended
j.p
jpm
key
kicks
lights
Language
unset
Current search:
home
×
biotech
×
" national blog main "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More